Member Info for CHELSEA7

Very true, and i wonder who said this.........................................

"""With regard to future announcements, as you are no doubt aware we have had a flurry of news flow over the last six months, including research partnerships (CRUK and BioNtech), technology licensing (Amplivant, for Modi-1), initiation of Modi-1 manufacturing, grant of Moditope patent by the EPO, publication of SCIB-1 clinical data, CRUK grand challenge shortlist, in-licensing of therapeutic antibodies and of course the recent capital raise of £8.7m. This is a lot for a small biotech company like Scancell to achieve and also assimilate in a relatively short period and I am confident that these activities will bear more fruit at which point we will keep the market informed.""

Well, i guess that told me, lol.

Good to see anyway, many thanks Ivy for sharing that, there is a period of seemingly no news, but i feel very reassured as to the changes evoked by news last January, Scancell fitting it all in to their structure and hearing timelines are equally as important to them.

A good use of BB space,!!! Have a good day all, sunshine beckons.

Morning Balerno, yeah RG seems to have freed CH up, in those six months since he took over. Many thanks to RG for his promptness and decency over a long period of time.

I understand your post, just one reason i choose to e-mail Scancell on occasions is to express my view.

Whilst understanding your feelings i don"t share them......now. I did for a short while. I can understand meticulously planning the trial and endpoints before IND submission. At the end of the day i was happy to see it hasn"t affected our plans........yet!!!! As for the SP, well as some know this fall from 15.5p has been irritating for me to watch, I expressed that in my e-mail, and respected the reply. I would say the IND matter will be imminantly sorted. ATB.

Ivy, thanks for that. Crumbs/Barbel lol.

Didn"t take you long did it.

"" Why did you persist in emailing RG when he has handed Exec. duties over to CH ?""...................Because that is the first time RG has passed it on to CH. Regardless i have built a very good rapport over six years, and meeting him four times.

You post : ''As we know Admin do not allow such posts, perfectly understandable as to why''. Well for one, I myself don't know why Admin. do not allow such posts or even why, if you know Admin don't allow it, why you should choose to post it."""

Because there are and have been morons who can easily change the text or make up a reply completely. That is why, and it saddens Admin to tell me. I shared this one, as i felt it would be of interest to others.....................no other reason.

"""If we all ask BoD a couple of questions we would be adding to the workload of a very busy BoD and to me, that's not a good idea. IMO best to let CH get on with his work."""...........................Yes you have stated that many times. Perhaps you simply don"t have any questions worth asking. Interesting thought, and clearly it is not worth building a rapport with them. I have found the whole team more than happy to discuss the science here over the years.

Anyway it seems we might have some confirmation that the SCIB1 Combo trial may still be on schedule and thanks for that much at least. However, if the trial might be slipping back, CH would not have been free to tell you would he ?
Pointless conversation, as ever. I would never tell you what relationship you should have as a shareholder. You, however, are trying to control mine.

"""In answer to your IND question, there has been a slight delay given the numerous moving parts in compiling the documentation some of which required third party input, however the IND is in the final stages of consistency checking and once complete it will go to publication. The agency is aware that a submission is forthcoming and subject to a favourable review we expect our study initiation to be on track for the end of this year which is the key event we are focussed on."""

I trust some will be happy to hear that.

https://www.investegate.co.uk/great-western-mining--gwmo-/rns/operational-update-and-placing/201807030700063395T/

Morning guys, I posted up a reply received yesterday from Chris Holloway here, concerning the SCIB1 IND and more importantly a very direct question as to whether the trial scheduled still by end 2018, will indeed still be on market. It got pulled after a few hours, so glad a few got to see it.

It was as direct a reply as it was a question, and i am sure like some others felt more than happy with his comments. As we know Admin do not allow such posts, perfectly understandable as to why, but as i say glad it stood for so long.

So the distinct impression was that matter will be completed very shortly, sounds to me as if by trial design, a third party, (American) has had some serious input with the IND (probably trial design) and after 28 days will be approved as per previously advised. More than encouraging to see CH replying now, and very happy replies are assured within 24 hours where possible.

So we stand at 12.5/12.8, a few buys popping up at 12.70, but volume very poor at 61k. Seems it really wasn"t long ago that many of us topped up in the OO, as to why it has been quieter than we would hope for.

Another day, thrilled with the weather forecast for July, endless blue days to embrace and heal. Every day cherised as today will be, and very happy with CHs e-mail. Sometimes we all need to ask just a couple of ,questions, so glad we have a CEO and BOD who respect that so much.

Good day to all, i was watching UKOG Level 2 on occasions yesterday, up to 20 trades a minute at certain points, over 5000 trades in a day. We can all dream..............................!!

Interesting Article.....................................

https://endpts.com/with-100m-in-fresh-backing-and-a-new-tcr-initiative-ipo-bound-athenex-launches-china-jv/?utm_medium=email&utm_campaign=512%20Mon%207218%20Scoop%20XTuit%20shuttered%20Deborah%20Dunsire%20takes%20over%20at%20Lundbeck%20Sanofi%20goes%20deep%20into%20China%20RD&utm_content=512%20Mon%207218%20Scoop%20XTuit%20shuttered%20Deborah%20Dunsire%20takes%20over%20at%20Lundbeck%20Sanofi%20goes%20deep%20into%20China%20RD+CID_2fdf3dcffb24d0e1b6ecbf12f966831a&utm_source=ENDPOINTS%20emails&utm_term=With%20100M%20in%20fresh%20backing%20and%20a%20new%20TCR%20initiative%20Athenex%20launches%20China%20JV

Buys 43k

Sells 18k

incl. NEX

https://endpts.com/roche-vaults-into-lead-in-frontline-triple-negative-breast-cancer-as-tecentriq-chemo-combo-aces-progression-free-survival/?utm_medium=email&utm_campaign=Monday%20July%202%202018&utm_content=Monday%20July%202%202018+CID_7d728fa0e6803cf1b8c1fc126faae945&utm_source=ENDPOINTS%20emails&utm_term=Roche%20vaults%20into%20lead%20in%20frontline%20triple%20negative%20breast%20cancer%20as%20Tecentriqchemo%20combo%20aces%20progression-free%20survival

At this point..............yes!!!

Well that is the dream, getting into all trials and finding a truer value.

Anybody who as written in about the IND and trial, will be sitting very relaxed.

Back to the sun!!

7800 for a bag of sand.

12.5/13...........................2v2

SCANCELL Retweeted

OBN
‏

@OBN_UK
Jun 27
More
We would like to welcome two more new OBN Members this week - @scancellpharma and https://circadiantherapeutics.com/

0 replies . 3 retweets 4 likes
Reply Retweet 3 Like 4
SCANCELL Retweeted

Chris Molloy
‏

@molloycr
Jun 14
More Chris Molloy Retweeted Andrew Morris
Medical Research Charities play a pivotal role in UK’s medicines R&D. Their #patientsfirst approach is a critical part of its future success @HDR_UK @MedDiscCat @AMRCChris Molloy added,

Andrew Morris

@profadmorris
Clear evidence of the impact of Medical Research Charities to the health and scientific footprint of the nation: £1.6B, 200,000 people participating in 1300 trials and 17,000 researchers salaries - a cornerstone in the UK’s quest…
0 replies . 7 retweets 18 likes
Reply Retweet 7 Like 18

Seems we are still following the Bonnie Addario, Cruk route..............................who"s next????

Morning All, time is flying,..........................it was only February that my carer returned from Hungary. Boy, i needed that.

Yesterday, she returned, job done by the angel from the East. Entering stage 2 recovery, responsibilities back and looking forward to regular trips to Budapest ( if i improve more), with my newly reinstated Passport.

Time does fly, been with me four years, hoping now as i had sort of planned for Scancell to start reflecting true value.

Only three months of summer stands between us and the AGM, A lot could happen, only five months to Grand Challenge results, and six till start of SCIB 1 Combo Trial.

Lets hope, the SP and news flow reflects that as we begin to find higher levels. GL All around the Casino, will not be playing it myself, holding my 120k here. No I haven"t lost any confidence here, just eager to hear where we are and what is coming. Have a good week all.

In fact I think sub 13p would never have been seen with news on that trial.

Interesting we fell to 12.5/12.8 for a short while before going back to 12.5/13p. So far no corresponding trade has been posted that gave cause to that.

Absolutely, and hasn"t that caused ripples through the Oncology Market.

I am pretty sure we are all excited about this trial, positive updates on trial timeline will, IMHO act as a catalyst here.

And all, welcome to Q3/H2!!!! Oh crap, better start thinking about Xmas!!!

Ivy yep, IND submission for trial now H2 in Hardman , trial date commence still end 2018. Lets trust we will meet it still. ATB.

Good article Rats, Roche keep coming up.